Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Sep 15;133(6):1271-85.
doi: 10.1002/ijc.27828. Epub 2012 Oct 11.

Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis

Affiliations
Meta-Analysis

Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis

Anne F Rositch et al. Int J Cancer. .

Abstract

Persistent high-risk human papillomavirus (HR-HPV) infection is the strongest risk factor for high-grade cervical precancer. We performed a systematic review and meta-analysis of HPV persistence patterns worldwide. Medline and ISI Web of Science were searched through January 1, 2010 for articles estimating HPV persistence or duration of detection. Descriptive and meta-regression techniques were used to summarize variability and the influence of study definitions and characteristics on duration and persistence of cervical HPV infections in women. Among 86 studies providing data on over 100,000 women, 73% defined persistence as HPV positivity at a minimum of two time points. Persistence varied notably across studies and was largely mediated by study region and HPV type, with HPV-16, 31, 33 and 52 being most persistent. Weighted median duration of any-HPV detection was 9.8 months. HR-HPV (9.3 months) persisted longer than low-risk HPV (8.4 months), and HPV-16 (12.4 months) persisted longer than HPV-18 (9.8 months). Among populations of HPV-positive women with normal cytology, the median duration of any-HPV detection was 11.5 and HR-HPV detection was 10.9 months. In conclusion, we estimated that approximately half of HPV infections persist past 6 to 12 months. Repeat HPV testing at 12-month intervals could identify women at increased risk of high-grade cervical precancer due to persistent HPV infections.

Keywords: HPV; cervical cancer; clearance; duration; human papillomavirus; literature review; meta-analysis; natural history; persistence; repeat testing; screening.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest statement:

Dr. Anne Rositch was directly supported for this project by GlaxoSmithKline (GSK) from 2006–2008 as a Graduate Student in the Department of Epidemiology at the University of North Carolina and was a Graduate Research Assistant at GSK from 2008–2009; Dr. Jill Koshiol was employed part-time by GSK from 2001–2005; Dr. Michael Hudgens, no conflict; Hilda Razzaghi has worked as a Graduate Research Assistant at both GSK and Merck in the last five years; Dr. Danielle Backes, no conflict; Dr. Jeanne Pimenta is an employee of GSK; Dr. Eduardo Franco has occasionally served on advisory boards at GSK, Merck, Roche, and Gen-Probe; Dr. Charles Poole receives partial salary support and has received lecture honoraria from GSK; Dr. Jennifer Smith has received grants and consulting fees in the last six years from GSK, Merck, Hologic, Qiagen, and Gen-Probe.

Figures

Figure 1
Figure 1
Forest Plots of the Median Duration of Infection by Human Papillomavirus Group or Type. Estimates are for human papillomavirus infections prevalent at baseline unless otherwise indicated, where * denotes incident infections and † denotes a mixture of prevalent and incident infections. The vertical line represents the overall, weighted median of 9.8 months.
Figure 1
Figure 1
Forest Plots of the Median Duration of Infection by Human Papillomavirus Group or Type. Estimates are for human papillomavirus infections prevalent at baseline unless otherwise indicated, where * denotes incident infections and † denotes a mixture of prevalent and incident infections. The vertical line represents the overall, weighted median of 9.8 months.
Figure 2
Figure 2
Estimates of the Proportion of Infections Persisting across Time for A) any-HPV, B) high-risk HPV, C) low-risk HPV, D) HPV type 16. The legend in each panel provides the references for articles that contributed data to each figure. The thick gray curve is a locally weighted polynomial regression (lowess) estimate based on data from all studies over all time points.
Figure 2
Figure 2
Estimates of the Proportion of Infections Persisting across Time for A) any-HPV, B) high-risk HPV, C) low-risk HPV, D) HPV type 16. The legend in each panel provides the references for articles that contributed data to each figure. The thick gray curve is a locally weighted polynomial regression (lowess) estimate based on data from all studies over all time points.
Figure 2
Figure 2
Estimates of the Proportion of Infections Persisting across Time for A) any-HPV, B) high-risk HPV, C) low-risk HPV, D) HPV type 16. The legend in each panel provides the references for articles that contributed data to each figure. The thick gray curve is a locally weighted polynomial regression (lowess) estimate based on data from all studies over all time points.
Figure 2
Figure 2
Estimates of the Proportion of Infections Persisting across Time for A) any-HPV, B) high-risk HPV, C) low-risk HPV, D) HPV type 16. The legend in each panel provides the references for articles that contributed data to each figure. The thick gray curve is a locally weighted polynomial regression (lowess) estimate based on data from all studies over all time points.
Figure 3
Figure 3
Age-Specific HPV Persistence. Estimates of the proportion of women with persistent human papillomavirus (HPV) infection by time are presented for any-HPV (squares) or high-risk HPV (circles). All results were based on prevalent infections unless otherwise noted, where* indicates HPV persistence based on incident infections. Some points were dithered slightly to avoid overlap.

Similar articles

Cited by

References

    1. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology. 2002;55:244–265. - PMC - PubMed
    1. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. Journal of Clinical Virology. 2000;19:1–5. - PubMed
    1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999;189:12–19. - PubMed
    1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Monograph on human papillomavirusesed. vol. 90: International Agency for Research on Cancer. 2007
    1. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. American journal of epidemiology. 2008;168:123–137. - PMC - PubMed

Publication types

MeSH terms